Dronedarone Hydrochloride/Ranolazine

盐酸决奈达隆/雷诺嗪

Report date: 2022/01/22 15:45:38

Base Information

Drug NameDronedarone Hydrochloride/Ranolazine

Drug Alias Name雷诺嗪盐酸决奈达隆Ranolazine/dronedarone盐酸决奈达隆雷诺嗪Dronedarone/ranolazineDronedarone Hydrochloride and Ranolazine +[6]

ClassificationSmall molecules

Mechanisms of ActionSodium channel alpha subunit blockersPotassium channel blockersVoltage-gated calcium channel blockers +[7]

TargetsPotassium channelSodium channel alpha subunitVoltage-gated calcium channel +[7]

Therapy Area/IndicationsAtrial Fibrillation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGilead Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsAtrial Fibrillation

ATC CodeN/A